Markers of adult endometriosis detectable in adolescence

Journal of Pediatric and Adolescent Gynecology

Volumn 24, Issue 5, 2011, Pages

  Chapron, Charles ^a,b   Borghese, Bruno ^a,b   Streuli, Isabelle ^a,b   De Ziegler, Dominique ^a  

^a Dept of Ob Gyn and Reproductive Medicine ^*  (France)

^b INSTITUT COCHIN   (France)

Author keywords

Adolescence; Endometriosis; Marker; Prediction

Indexed keywords

DANAZOL; GONADORELIN; ORAL CONTRACEPTIVE AGENT;

ADOLESCENCE; ADOLESCENT; ARTHRALGIA; ARTICLE; CLINICAL ASSESSMENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; FOLLICULAR PHASE; GENETIC PREDISPOSITION; HOT FLUSH; HUMAN; INTRAUTERINE PRESSURE; MENSTRUAL CYCLE; OSTEOLYSIS; OSTEOPOROSIS; OVULATION; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; STAGING; UTERUS CONTRACTILITY; VAGINA ATROPHY;

ADOLESCENT; ADULT; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HUMANS;

EID: 80051826513     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2011.07.006     Document Type: Article

References (49)

1. Chapron C., Lafay-Pillet M.C., Monceau E., et al. Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis. Fertil Steril 2011, 95:877-881.
2. Taipale K., Leminen A., Rasanen P., et al. Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders. Acta Obstet Gynecol Scand 2009, 88:1402-1410.
3. Giudice L.C. Clinical practice. Endometriosis. New Engl J Med 2010, 362:2389-2398.
4. Stephansson O., Kieler H., Granath F., et al. Endometriosis, Assisted reproduction technology, and risk of adverse pregnancy outcome. Human Reprod 2009, 24:2341-2347.
5. Somigliana E., Vercellini P., Vigano P., et al. Non-invasive diagnosis of endometriosis: the goal or own goal?. Hum Reprod 2010, 25:1863-1868.
6. Chapron C., Souza C., de Ziegler D., et al. Smoking habits of 411 women with histologically proven endometriosis and 567 unaffected women. Fertil Steril 2010, 94:2353-2355.
7. Vercellini P., Meana M., Hummelshoj L., et al. Priorities for endometriosis research: a proposed focus on deep dyspareunia. Reprod Sci 2011, 18:114-118.
8. Bulletti C., De Ziegler D., Setti P.L., et al. The patterns of uterine contractility in normal menstruating women: from physiology to pathology. Ann N Y Acad Sci 2004, 1034:64-83.
9. de Ziegler D., Bulletti C., Fanchin R., et al. Contractility of the nonpregnant uterus: the follicular phase. Ann N Y Acad Sci 2001, 943:172-184.
10. Bulletti C., de Ziegler D. Uterine contractility and embryo implantation. Curr Opin Obstet Gynecol 2006, 18:473-484.
11. Togashi K. Uterine contractility evaluated on cine magnetic resonance imaging. Ann N Y Acad Sci 2007, 1101:62-71.
12. Kunz G., Beil D., Deininger H., et al. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996, 11:627-632.
13. Liedman R., Grant L., Igidbashian S., et al. Intrauterine pressure, ischemia markers, and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhea. Acta Obstet Gynecol Scand 2006, 85:207-211.
14. Kissler S., Zangos S., Wiegratz I., et al. Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis. Ann N Y Acad Sci 2007, 1101:38-48.
15. Bulletti C., De Ziegler D., Polli V., et al. Characteristics of uterine contractility during menses in women with mild to moderate endometriosis. Fertil Steril 2002, 77:1156-1161.
16. Fauconnier A., Chapron C. Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update 2005, 11:595-606.
17. Laufer M.R., Goitein L., Bush M., et al. Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 1997, 10:199-202.
18. Treloar S.A., Bell T.A., Nagle C.M., et al. Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol 2010, 202:534.e1-534.e6.
19. Vercellini P., Crosignani P., Somigliana E., et al. " Waiting for Godot": a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011, 26:3-13.
20. Doyle J.O., Missmer S.A., Laufer M.R. The effect of combined surgical-medical intervention on the progression of endometriosis in an adolescent and young adult population. J Pediatr Adolesc Gynecol 2009, 22:257-263.
21. Chapron C., Souza C., Borghese B., et al. Oral contraceptives (OC) and endometriosis: the past use of OC for treating severe primary dysmenorrhea appears as a marker associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011, 26:2028-2035.
22. Schriock E., Monroe S.E., Henzl M., et al. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). Fertil Steril 1985, 44:583-588.
23. Henzl M.R., Corson S.L., Moghissi K., et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. New Engl J Med 1988, 318:485-489.
24. Cedars M.I., Lu J.K., Meldrum D.R., et al. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol 1990, 75:641-645.
25. Selak V., Farquhar C., Prentice A., et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2000, CD000068.
26. Prentice A., Deary A.J., Goldbeck-Wood S., et al. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2000, CD000346.
27. Surrey E.S. Steroidal and nonsteroidal " add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient. Fertil Steril 1995, 64:673-685.
28. Bedaiwy M.A., Casper R.F. Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain. Fertil Steril 2006, 86:220-222.
29. Mizutani T., Nishiyama S., Amakawa I., et al. Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository. Fertil Steril 1995, 63:1184-1189.
30. Vercellini P., Frontino G., De Giorgi O., et al. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003, 80:560-563.
31. Chapron C., Chopin N., Borghese B., et al. Deeply infiltrating endometriosis: pathogenetic implications of the anatomical distribution. Hum Reprod 2006, 21:1839-1845.
32. Jain S., Dalton M.E. Chocolate cysts from ovarian follicles. Fertil Steril 1999, 72:852-856.
33. Fraser I.S., Kovacs G.T. The efficacy of non-contraceptive uses for hormonal contraceptives. Med J Aust 2003, 178:621-623.
34. Parazzini F., Ferraroni M., Bocciolone L., et al. Contraceptive methods and risk of pelvic endometriosis. Contraception 1994, 49:47-55.
35. Vercellini P., Eskenazi B., Consonni D., et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 2011, 17:159-170.
36. Simpson J.L., Elias S., Malinak L.R., et al. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980, 137:327-331.
37. Stefansson H., Geirsson R.T., Steinthorsdottir V., et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002, 17:555-559.
38. Treloar S.A., O'Connor D.T., O'Connor V.M., et al. Genetic influences on endometriosis in an Australian twin sample. Fertil Steril 1999, 71:701-710.
39. Treloar S.A., Wicks J., Nyholt D.R., et al. Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet 2005, 77:365-376.
40. Treloar S.A., Zhao Z.Z., Le L., et al. Variants in EMX2 and PTEN do not contribute to risk of endometriosis. Mol Hum Reprod 2007, 13:587-594.
41. Di W., Guo S.W. The search for genetic variants predisposing women to endometriosis. Curr Opin Obstet Gynecol 2007, 19:395-401.
42. Uno S., Zembutsu H., Hirasawa A., et al. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet 2010, 42:707-710.
43. Painter J.N., Anderson C.A., Nyholt D.R., et al. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 2011, 43:51-54.
44. Borghese B., Chiche J.D., Vernerey D., et al. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum Reprod 2008, 23:1207-1213.
45. Borghese B., Mondon F., Noel J.C., et al. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol 2008, 22:2557-2562.
46. Borghese B., Barbaux S., Mondon F., et al. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol 2010, 24:1872-1885.
47. Chopin N., Vieira M., Borghese B., et al. Operative management of deeply infiltrating endometriosis: results on pelvic pain symptoms according to a surgical classification. J Minim Invasive Gynecol 2005, 12:106-112.
48. Chapron C., Dubuisson J.B., Pansini V., et al. Routine clinical examination is not sufficient for diagnosing and locating deeply infiltrating endometriosis. J Am Assoc Gynecol Laparosc 2002, 9:115-119.
49. Piketty M., Chopin N., Dousset B., et al. Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination. Hum Reprod 2009, 24:602-607.